German pharmaceutical firm Boehringer Ingelheim has selected Certara's D360 as its global drug discovery platform, which will help in sharing discovery data across global working groups that can include external collaborators. Certara is ...
Global pharmaceutical company Zydus Cadila and Pieris, a therapeutic protein research and development company, have entered into an alliance for development and commercialization of multiple novel Anticalin-based protein therapeutics. The ...
Biopharmaceutical firm Berg and the Icahn School of Medicine at Mount Sinai have entered into a pharmaceutical and diagnostic R&D deal to leverage the power of multi-omic biology and data analytics. The deal is intended to secure new ...
US-based drug discovery and development firm, Heptares Therapeutics has delivered the first stabilised G protein-coupled receptor (GPCR) called 'StaR' to MorphoSys for antibody discovery as part of their antibody therapeutics alliance. ...
Tags: Heptares Therapeutics, drug
The Agency for Science, Technology and Research (A*STAR)'s Experimental Therapeutics Centre (ETC) and Swiss biopharmaceutical firm Debiopharm Group (Debiopharm) have signed an exclusive research collaboration to develop oral small molecules ...
Tags: Cancer Drugs, Medicine
Japanese pharmaceutical firm PeptiDream and France-based Ipsen have expanded their research collaboration and license option agreement signed in April 2013 to develop peptide drugs to treat serious endocrinologic disease. The deal has now ...
Tags: PeptiDream, Ipsen, peptide drugs
US-based biotechnology company X-Chem and UK-based pharmaceutical company AstraZeneca have entered into an expanded global drug discovery collaboration that covers all of AstraZeneca’s therapeutic areas and multiple target classes. ...
Tags: Drug, pharmaceutical
CureDuchenne has launched a new drug discovery and development initiative to identify and develop a pipeline of therapies to treat Duchenne muscular dystrophy. The initiative, dubbed CureDuchenne Ventures, is based on the company's ...
US-biotechnology company Labcyte has partnered with AstraZeneca to develop acoustic sample handling for mass spectrometry to advance drug discovery applications. Biotechnology tools firm Labcyte has recently developed techniques for the ...
Tags: Labcyte Partners
Accelrys, a US-based provider of lifecycle management solutions, has completed the roll-out of its next-generation cheminformatics suite, with the launch of Accelrys Insight and Accelrys Insight for Excel. Both the solutions will help in ...
Tags: lifecycle management, Medicine
Japanese drugmaker Otsuka Pharmaceutical has agreed to acquire Astex Pharmaceuticals for $866m in an all-cash tender offer. Under the deal, Astex's fragment-based drug design technology called 'PYRAMID' will be integrated into Otsuka, ...
Scientists from the University of Strathclyde have invented a unique computer technology that helps in the discovery of smarter drugs to treat major disease, including heart ailments. Dubbed as Shapeshifting Inspired Discovery (SID), the ...
Tags: Faster Drug Discovery, Medicine
Certara, a provider of software and scientific consulting services for drug discovery, has announced the acquisition of Great Lakes Drug Development, a consultancy firm (GLDD) based in Brighton, Michigan. The acquisition is expected to ...
Tags: Certara, Lakes Drug Development
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
Sunovion Pharma and San Diego-based drug discovery platform company Afraxis have entered into a partnership agreement to use the unique enhanced spine platform (ESP), to boost Sunovion’s preclinical central nervous system (CNS) drug ...
Tags: Sunovion Pharma, Afraxis